CINGAL
-
Biologics
Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated with Osteoarthritis
October 25, 2017 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based…
Read More » -
Extremities
Anika Announces Publication of Phase III Data Demonstrating the Efficacy and Safety of CINGAL®
May 22, 2017 08:30 AM Eastern Daylight Time BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines…
Read More » -
Top Stories
Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis
June 01, 2016 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics…
Read More » -
Extremities
Anika Therapeutics Announces Canadian Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its…
Read More » -
Extremities
Anika Therapeutics Wins CE Mark Approval for Cingal® for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its…
Read More » -
Hospitals
Anika Therapeutics Announces Decision to Proceed with CINGAL® Premarket Review Through FDA’s Center for Drug Evaluation and Research
BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic…
Read More » -
Hospitals
Anika Therapeutics Announces Health Canada Approval of CINGAL® for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary…
Read More » -
Extremities
Anika Therapeutics Announces Positive Results from Follow-up Study Evaluating Safety of a Repeat Injection of CINGAL for Treatment of Osteoarthritis of the Knee
BEDFORD, Mass., Jul 09, 2015 (BUSINESS WIRE) — Anika Therapeutics, Inc., ANIK, +0.35% a leader in products for tissue protection, healing, and repair based…
Read More »